FDA Issues Warning Letter to Trew Balance
September 03, 2025
September 03, 2025
WASHINGTON, Sept. 3 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Trew Balance from Center for Drug Evaluation and Research:
* * *
Recipient: Sheelah Golliglee, President, Trew Balance, 11200 W. Michigan Ave. Suite #3, Youngtown, AZ 85363, United States, youngtownclinic@gmail.com, info@trewbalance.com
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
. . .
* * *
Recipient: Sheelah Golliglee, President, Trew Balance, 11200 W. Michigan Ave. Suite #3, Youngtown, AZ 85363, United States, youngtownclinic@gmail.com, info@trewbalance.com
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
. . .